Insider Transactions in Q2 2023 at Processa Pharmaceuticals, Inc. (PCSA)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2023
|
Justin W Yorke |
BUY
Exercise of conversion of derivative security
|
Direct |
23,636
+29.41%
|
-
|
|
Jun 27
2023
|
James R Neal |
BUY
Exercise of conversion of derivative security
|
Direct |
14,407
+50.0%
|
-
|
|
Jun 27
2023
|
Khoso Baluch |
BUY
Exercise of conversion of derivative security
|
Direct |
15,455
+35.6%
|
-
|
|
Jun 27
2023
|
Virgil Thompson |
BUY
Exercise of conversion of derivative security
|
Indirect |
23,636
+16.03%
|
-
|
|
Jun 27
2023
|
Geraldine Pannu |
BUY
Exercise of conversion of derivative security
|
Direct |
23,636
+30.8%
|
-
|
|
Jun 12
2023
|
David Young Pres. Research & Development |
BUY
Open market or private purchase
|
Direct |
40,000
+7.84%
|
$0
$0.8 P/Share
|
|
Apr 14
2023
|
David Young Pres. Research & Development |
BUY
Open market or private purchase
|
Direct |
20,000
+4.44%
|
$0
$0.55 P/Share
|
|
Apr 13
2023
|
David Young Pres. Research & Development |
BUY
Open market or private purchase
|
Direct |
20,000
+4.65%
|
$0
$0.48 P/Share
|
|
Apr 12
2023
|
David Young Pres. Research & Development |
BUY
Open market or private purchase
|
Direct |
20,000
+4.87%
|
$0
$0.45 P/Share
|
|
Apr 11
2023
|
David Young Pres. Research & Development |
BUY
Open market or private purchase
|
Direct |
20,000
+5.12%
|
$0
$0.52 P/Share
|